Prof. Gary Evans

Chief Science Advisor

MBIE

Prof Gary Evans is a Medicinal Chemist based at Victoria University of Wellington’s Ferrier Research Institute and is seconded for 80% of his time to the Ministry of Business, Innovation and Employment as their Chief Science Advisor where he heads the Science Leadership team. His research involves drug development, designing and synthesising enzyme inhibitors for treating and combating disease. He invented the drug Ulodesine, which completed Phase II clinical trials for the treatment of gout. He was also part the team that synthesised Mundesine which has been approved in Japan for the treatment of peripheral T-Cell lymphoma. Prof Evans earned his PhD at Otago University, before accepting a postdoctoral position at Oxford University. He then worked in the biotechnology sector in United Kingdom. He was appointed a Member of NZ Order of Merit in 2014 and has received several prestigious awards, including the 2014 Janssen Best Innovation Award, the 2011 MacDiarmid Medal from the Royal Society of New Zealand, and the 2004 Nufarm Prize for Excellence in Industrial and Applied Chemistry.